Pfizer Ltd
PFIZER
Company Profile
Business description
Pfizer Ltd is engaged in manufacturing, marketing, trading and export of pharmaceutical products. The company has only one segment which is Pharmaceuticals and it operates in domestic market.
Contact
The Capital, 1802/1901
18th Floor, Plot No. C - 70, G Block
Bandra Kurla Complex
Bandra (East)
MumbaiMH400 051
INDT: +91 2266932000
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - General
Fiscal Year End
31 March 2025
Employees
1,931
Pfizer Ltd News & Analysis
stocks
Vaccine rollout and herd immunity to end the pandemic
Covid will create a $52bn vaccine and treatment market and usher in immunity by 2023, writes Morningstar's Karen Andersen.
markets
A light at the end of the covid tunnel
It was a week that brought significant news on multiple fronts, including the announcement of an effective coronavirus vaccine and a troubling end to the marathon American presidential election cycle.
markets
Morningstar runs the numbers
We take a numerical look through this week's Morningstar research. Plus, our most popular articles and videos for the week ended 10 January.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,450.90 | 64.30 | -0.76% |
| CAC 40 | 7,226.98 | 199.90 | -2.69% |
| DAX 40 | 19,033.64 | 414.96 | -2.13% |
| Dow JONES (US) | 43,910.98 | 382.15 | -0.86% |
| FTSE 100 | 8,025.77 | 99.42 | -1.22% |
| HKSE | 19,705.97 | 140.91 | -0.71% |
| NASDAQ | 19,281.40 | 17.36 | -0.09% |
| Nikkei 225 | 38,716.37 | 659.72 | -1.68% |
| NZX 50 Index | 12,674.49 | 74.87 | -0.59% |
| S&P 500 | 5,983.99 | 17.36 | -0.29% |
| S&P/ASX 200 | 8,193.40 | 62.20 | -0.75% |
| SSE Composite Index | 3,428.77 | 6.80 | 0.20% |